Measurement of mucosal biomarkers in a phase 1 trial of intravaginal 3% StarPharma LTD 7013 gel (VivaGel) to assess expanded safety (Q35681023)

From Wikidata
Jump to navigation Jump to search
scientific article published on February 2012
edit
Language Label Description Also known as
English
Measurement of mucosal biomarkers in a phase 1 trial of intravaginal 3% StarPharma LTD 7013 gel (VivaGel) to assess expanded safety
scientific article published on February 2012

    Statements

    Measurement of mucosal biomarkers in a phase 1 trial of intravaginal 3% StarPharma LTD 7013 gel (VivaGel) to assess expanded safety (English)
    Anna-Barbara Moscicki
    Mark E Scott
    Ibrahim I Daud
    Stephen Shiboski
    Anuradha Rebbapragada
    Sanja Huibner
    1 February 2012

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit